Chiang, Kun-Chun <br/><br/>
Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.  [electronic resource] 

 -  Scientific reports  Jul 2014 
 - 5511 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep05511  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cisplatin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Immediate-Early Proteins--metabolism<br/>Male<br/>Prostatic Neoplasms--drug therapy<br/>Protein Serine-Threonine Kinases--metabolism<br/>Signal Transduction--drug effects<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--metabolism<br/>Tumor Suppressor Proteins--metabolism<br/>NF-kappaB-Inducing Kinase